Mesoblast Limited Statistics
Share Statistics
Mesoblast Limited has 1.14B shares outstanding. The number of shares has increased by -36.66% in one year.
| Shares Outstanding | 1.14B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -1.4% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 851.12M |
| Failed to Deliver (FTD) Shares | 11.58K |
| FTD / Avg. Volume | 5.55% |
Short Selling Information
The latest short interest is 1.39M, so 1.21% of the outstanding shares have been sold short.
| Short Interest | 1.39M |
| Short % of Shares Out | 1.21% |
| Short % of Float | 0.16% |
| Short Ratio (days to cover) | 6.69 |
Valuation Ratios
The PE ratio is -7.48 and the forward PE ratio is -18.09.
| PE Ratio | -7.48 |
| Forward PE | -18.09 |
| PS Ratio | 111.47 |
| Forward PS | 21.1 |
| PB Ratio | 1.37 |
| P/FCF Ratio | -13.48 |
| PEG Ratio | n/a |
Enterprise Valuation
Mesoblast Limited has an Enterprise Value (EV) of 655.11M.
| EV / Earnings | -7.45 |
| EV / Sales | 111 |
| EV / EBITDA | -10.43 |
| EV / EBIT | -11.14 |
| EV / FCF | -13.43 |
Financial Position
The company has a current ratio of 1.18, with a Debt / Equity ratio of 0.24.
| Current Ratio | 1.18 |
| Quick Ratio | 1.18 |
| Debt / Equity | 0.24 |
| Total Debt / Capitalization | 19.23 |
| Cash Flow / Debt | -0.42 |
| Interest Coverage | -2.81 |
Financial Efficiency
Return on equity (ROE) is -0.18% and return on capital (ROIC) is -9.79%.
| Return on Equity (ROE) | -0.18% |
| Return on Assets (ROA) | -0.13% |
| Return on Capital (ROIC) | -9.79% |
| Revenue Per Employee | 80.85K |
| Profits Per Employee | -1.20M |
| Employee Count | 73 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | -191.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 450.93% in the last 52 weeks. The beta is 2.34, so Mesoblast Limited's price volatility has been higher than the market average.
| Beta | 2.34 |
| 52-Week Price Change | 450.93% |
| 50-Day Moving Average | 10.02 |
| 200-Day Moving Average | 7.18 |
| Relative Strength Index (RSI) | 48.18 |
| Average Volume (20 Days) | 208.68K |
Income Statement
In the last 12 months, Mesoblast Limited had revenue of $5.90M and earned -$87.96M in profits. Earnings per share was $-0.89.
| Revenue | 5.90M |
| Gross Profit | -9.81M |
| Operating Income | -58.79M |
| Net Income | -87.96M |
| EBITDA | -62.82M |
| EBIT | -58.79M |
| Earnings Per Share (EPS) | -0.89 |
Balance Sheet
The company has $62.96M in cash and $118.92M in debt, giving a net cash position of -$55.96M.
| Cash & Cash Equivalents | 62.96M |
| Total Debt | 118.92M |
| Net Cash | -55.96M |
| Retained Earnings | -908.76M |
| Total Assets | 669.15M |
| Working Capital | 13.22M |
Cash Flow
In the last 12 months, operating cash flow was -$48.46M and capital expenditures -$271.00K, giving a free cash flow of -$48.79M.
| Operating Cash Flow | -48.46M |
| Capital Expenditures | -271.00K |
| Free Cash Flow | -48.79M |
| FCF Per Share | -0.05 |
Margins
Gross margin is 100%, with operating and profit margins of -982.24% and -1.49K%.
| Gross Margin | 100% |
| Operating Margin | -982.24% |
| Pretax Margin | -1.49K% |
| Profit Margin | -1.49K% |
| EBITDA Margin | -1.06K% |
| EBIT Margin | -996.17% |
| FCF Margin | -826.65% |
Dividends & Yields
MESO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -7.55% |
| FCF Yield | -3.61% |
Analyst Forecast
The average price target for MESO is $11.5, which is -2.5% lower than the current price. The consensus rating is "Buy".
| Price Target | $11.5 |
| Price Target Difference | -2.5% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Jan 10, 2024. It was a backward split with a ratio of 1:2.
| Last Split Date | Jan 10, 2024 |
| Split Type | backward |
| Split Ratio | 1:2 |
Scores
| Altman Z-Score | 1.68 |
| Piotroski F-Score | 1 |